Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...

Antidepressant use prior to traumatic brain injury was not associated with worse short-term outcomes for individuals ...

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

More than one-third of patients with cutaneous chronic graft-versus-host disease had a perception of treatment response that ...

Girls who develop polycystic ovary syndrome and metabolic dysfunction-associated steatotic liver disease as adolescents have increased risk for adverse cardiometabolic outcomes as adults, according to ...

In December, the FDA granted breakthrough status for an implantable kidney replacement system for patients with end-stage kidney disease, according to a company press release.The Holly device by ...

Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...

Offspring of women aged 35 years or older vs. 25 to 29 years at childbirth were less likely to have food allergy reactions, ...

Political ideology is linked to Americans’ trust in scientists as sources of cancer information, study results suggest.A ...

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, according to a press release from manufacturer Biogen. Litifilimab (Biogen) is a ...

A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the ...

The American Telemedicine Association, or ATA, urged Congress to quickly act to avoid the expiration of key telehealth services on Jan. 30, which are being threatened by an “unrelated partisan debate.